Larvol Delta - ARTEMIDELung03-A-Global-Phase-III-Study-of-Rilvegostomig-or-Pembrolizumab-Plus-Chemotherapy-for-FirstLine-Treatment-of-Locally-Advanced-or-Metastatic-NonSquamous-NSCLC

pemetrexed - Generic mfg.

carboplatin - Generic mfg.

rilvegostomig (AZD2936) - AstraZeneca

Keytruda (pembrolizumab) - Merck (MSD)

cisplatin - Generic mfg.

http://clinicaltrials.gov/ct2/show/NCT06627647

Jul 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next